Topical Tranexamic Acid After Intravitreal Injections
Not Applicable
- Conditions
- Subconjunctival Hemorrhage
- Interventions
- Other: Balanced Salt Solution
- Registration Number
- NCT04400916
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
We aim to investigate whether topical administration of Tranexamic acid can reduce the occurence of subconjunctival hemorrahge after routine intravitreal injections for retinal conditions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Subjects receiving intravitreal injections as part of their routine ophthalmological care
Exclusion Criteria
Pregnancy, Oral contraceptives/HRT use, Known systemic autoimmune disease, Renal failure, active/suspected infection or inflammation in the treated eye, subconjunctival hemorrahge prior to inclusion, History of subarachnoid hemorrahge, thromboembolic events, increased risk for thromboembolic events, known sensitivity to the study drug
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Topical BSS Balanced Salt Solution - Topical tranexamic acid Tranexamic acid -
- Primary Outcome Measures
Name Time Method Subconjunctival hemorrahge 3 days
- Secondary Outcome Measures
Name Time Method